CH336074A - Process for the preparation of 2-oxo-4,5-dihydroxy-4-carboxy-5-ureido-imidazolidine - Google Patents

Process for the preparation of 2-oxo-4,5-dihydroxy-4-carboxy-5-ureido-imidazolidine

Info

Publication number
CH336074A
CH336074A CH336074DA CH336074A CH 336074 A CH336074 A CH 336074A CH 336074D A CH336074D A CH 336074DA CH 336074 A CH336074 A CH 336074A
Authority
CH
Switzerland
Prior art keywords
imidazolidine
ureido
oxo
carboxy
dihydroxy
Prior art date
Application number
Other languages
German (de)
Inventor
Jakob Dr Brandenberger Hans
Original Assignee
Jakob Dr Brandenberger Hans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jakob Dr Brandenberger Hans filed Critical Jakob Dr Brandenberger Hans
Publication of CH336074A publication Critical patent/CH336074A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

   <Desc/Clms Page number 1> 
 Verfahren zur    Herstellung   von    2-Oxo-4,5-dihydroxy-4-earboxy-5-ureido-imidazolidin   Gegenstand vorliegenden Patentes bildet ein Verfahren zur Herstellung von    2-Oxo-4,5-diyhdroxy-4-      carboxy-5-ureido-imidazolidin.   Das Verfahren ist dadurch gekennzeichnet, dass man Harnsäure in alkalischer Lösung oxydiert, das Reaktionsprodukt vorerst als Satz    isoliert   und nach einer eventuellen Reinigung in die freie Säure überführt. 



  Die Isolierung des Salzes aus dem Reaktionsgemisch kann zum Beispiel dadurch geschehen, dass man die Lösung auf kleines Volumen eindampft und die Verbindung kristallisieren lässt. Die Säure lässt sich aber auch als    Schwermetallsalz   direkt aus dem Reaktionsgemisch fällen. Eine eventuelle Reinigung der Verbindung geschieht zweckmässig durch Umkristallisation ihres    Alkalisalzes   aus Wasser. Die Überführung in das freie    2-Oxo-4,5-dihdroxy-4-      carboxy-5-ureido-imidazolidin   kann zum' Beispiel durch starkes Ansäuern einer wässerigen Lösung des Salzes erfolgen, wobei zur Erhöhung der Ausbeute zweckmässig in der Kälte gearbeitet wird. 



  2 -    Oxo   - 4,5 -    dihydroxy-4-carboxy-5-ureido-imi-      dazolidin   bildet schwere, farblose Kristalle, die bei 165  unter Zersetzung    schmelzen.   



  Die freie Säure oder    ihr   Salz soll als Zwischenprodukt für die Herstellung von Heilmitteln verwendet werden. 



  Beispiel 4 g Harnsäure werden in 10 ml Wasser suspendiert und einer Lösung von 8 g    KOH   in 50    ml   Wasser zugesetzt. Nach vollständiger Lösung (von Spuren Ungelöstem muss eventuell    abfiltriert   werden) wird auf 5  oder darunter gekühlt und unter gutem Mischen in    kleinen   Portionen eine Lösung von 2,5g    KMn04   in 50 ml Wasser zugegeben. Nun wird mehrere Stunden in der    Kälte   stehengelassen, etwas    Alkohol   zugesetzt und das    ausgeflockte      MnO,   abgesaugt. Nach Einengen im Vakuum oder bei Normaldruck unter    N2   kristallisiert aus kleinem Volumen das    Alkalisalz   der Säure.

   Aus der Mutterlauge kann meist noch eine zweite Fraktion gewonnen werden.    Umkristallisieren   aus heissem Wasser liefert über 2 g    Kaliumsalz.   Dieses wird in der zehnfachen Menge warmem Wasser gelöst und nach dem Abkühlen auf    Zimmertemperatur   mit    HCl   stark angesäuert. Die freie Säure scheidet sich langsam in schweren Kristallen ab. Ausbeute: zwischen 1 und 1,5 g.



   <Desc / Clms Page number 1>
 Process for the preparation of 2-oxo-4,5-dihydroxy-4-earboxy-5-ureido-imidazolidine The subject of the present patent forms a process for the preparation of 2-oxo-4,5-diyhdroxy-4-carboxy-5-ureido- imidazolidine. The process is characterized in that uric acid is oxidized in an alkaline solution, the reaction product is initially isolated as a batch and, after any purification, converted into the free acid.



  The salt can be isolated from the reaction mixture, for example, by evaporating the solution to a small volume and allowing the compound to crystallize. The acid can also be precipitated directly from the reaction mixture as a heavy metal salt. Any purification of the compound is expediently done by recrystallizing its alkali salt from water. The conversion into the free 2-oxo-4,5-dihdroxy-4-carboxy-5-ureido-imidazolidine can be carried out, for example, by strongly acidifying an aqueous solution of the salt, in which case it is advisable to work in the cold to increase the yield.



  2 - Oxo - 4,5 - dihydroxy-4-carboxy-5-ureido-imidazolidine forms heavy, colorless crystals which melt at 165 with decomposition.



  The free acid or its salt is said to be used as an intermediate in the manufacture of medicines.



  Example 4 g of uric acid are suspended in 10 ml of water and added to a solution of 8 g of KOH in 50 ml of water. After complete dissolution (traces of undissolved material may have to be filtered off), the mixture is cooled to 5 or below and a solution of 2.5 g KMn04 in 50 ml water is added in small portions with thorough mixing. It is now left to stand in the cold for several hours, a little alcohol is added and the flocculated MnO is suctioned off. After concentration in vacuo or at normal pressure under N2, the alkali salt of the acid crystallizes from a small volume.

   A second fraction can usually be obtained from the mother liquor. Recrystallization from hot water yields over 2 g of the potassium salt. This is dissolved in ten times the amount of warm water and, after cooling to room temperature, strongly acidified with HCl. The free acid slowly separates out in heavy crystals. Yield: between 1 and 1.5 g.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von 2-Oxo-4,5-di- hydroxy-4-carboxy-5-ureido-imidazolidin durch Oxydation von Harnsäure in alkalischer Lösung, Isolierung des erhaltenen Salzes und seine überführung in die freie Säure. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als Oxydationsmittel KMn04 verwendet. 2. Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als Oxydationsmittel H202 in der Kälte verwendet. 3. Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als Oxydationsmittel Mn02 verwendet. 4. Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als Oxydationsmittel Pb02 verwendet. PATENT CLAIM Process for the production of 2-oxo-4,5-di-hydroxy-4-carboxy-5-ureido-imidazolidine by oxidation of uric acid in alkaline solution, isolation of the salt obtained and its conversion into the free acid. SUBClaims 1. Method according to claim, characterized in that KMn04 is used as the oxidizing agent. 2. The method according to claim, characterized in that the oxidizing agent used is H202 in the cold. 3. The method according to claim, characterized in that the oxidizing agent used is Mn02. 4. The method according to claim, characterized in that the oxidizing agent used is Pb02.
CH336074D 1955-06-01 1955-06-01 Process for the preparation of 2-oxo-4,5-dihydroxy-4-carboxy-5-ureido-imidazolidine CH336074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH336074T 1955-06-01

Publications (1)

Publication Number Publication Date
CH336074A true CH336074A (en) 1959-02-15

Family

ID=4503793

Family Applications (1)

Application Number Title Priority Date Filing Date
CH336074D CH336074A (en) 1955-06-01 1955-06-01 Process for the preparation of 2-oxo-4,5-dihydroxy-4-carboxy-5-ureido-imidazolidine

Country Status (1)

Country Link
CH (1) CH336074A (en)

Similar Documents

Publication Publication Date Title
CH336074A (en) Process for the preparation of 2-oxo-4,5-dihydroxy-4-carboxy-5-ureido-imidazolidine
DE1939924B2 (en) PROCESS FOR THE PREPARATION OF ALLANTOIN IN AQUATIC MEDIUM
DE836800C (en) Process for the preparation of 21-oxy-pregnen- (5) -ol- (3) -one- (20) -Abkoemmlingen
US2717266A (en) Production of pentadecanedioic acid
AT207383B (en) Process for the preparation of sulfonylureas
AT230370B (en) Process for the production of new sulfonamides
AT205027B (en) Process for the preparation of new α-aroyl-α-phthaliminoacetic acid esters
AT227696B (en) Process for the preparation of 2-amino-oxazoles
DE953701C (en) Process for the preparation of sulfobenzoic acid or its salts
CH305891A (en) Process for the preparation of isonicotinic acid hydrazide.
AT228190B (en) Process for the preparation of new hydrazine derivatives and their salts
AT275504B (en) Process for the purification of 2,5-dihydroxyterephthalic acid
DE528113C (en) Process for the preparation of pyridinarsic acids
DE883156C (en) Process for the preparation of 2-amino-4-sulfamido-phenylarsinic acid
AT92407B (en) Process for the preparation of 1-allyl-3,7-dimethylxanthine.
AT205026B (en) Process for the preparation of new α-aroyl-α- (o-carboxybenzoylamino) -acetic acid esters
AT92398B (en) Process for the preparation of the alkali and alkaline earth salts of benzylphthalamic acid.
DE955510C (en) Process for the preparation of a heterocyclic quinone
AT209899B (en) Process for the preparation of isoxazolidone compounds
CH278184A (en) Process for the preparation of an acylaminoacetoacetic ester.
CH374981A (en) Process for the preparation of sulfonylureas
CH374643A (en) Process for the preparation of sulfonylureas
DE2532124B2 (en) Process for the production of 4-amino-morpholine
CH237127A (en) Process for the preparation of 4-amino-benzenesulfondodecanoylamide.
DD141924B1 (en) Process for the preparation of hydroquinone monosulfonic acid calcium